Company Filing History:
Years Active: 1989-1999
Title: Innovations of Lawrence L Leppert in Extracorporeal Blood Treatment
Introduction
Lawrence L Leppert is a notable inventor based in Littleton, Colorado, recognized for his contributions to medical technology. He holds three patents that focus on advanced techniques for the extracorporeal treatment of blood. His work has significantly impacted the field of blood treatment, enhancing patient care and safety.
Latest Patents
One of Leppert's latest patents describes a technique for extracorporeal treatment of blood. This innovative method involves the flow of blood from a patient into a primary chamber of a filtration unit. The blood passes through a semipermeable membrane, which separates the primary chamber from a secondary chamber. The system allows for the selective and controllable addition of a replacement fluid to the blood as required for the selected treatment. Additionally, a secondary fluid is introduced into the secondary chamber to collect materials or supply necessary substances to the blood. The apparatus automatically detects blood leaks and adjusts the rates of blood and fluid flow accordingly, ensuring optimal treatment conditions.
Career Highlights
Leppert's career is marked by his dedication to improving medical technologies. He has worked with Cobe Laboratories, Inc., where he has collaborated with other professionals in the field. His innovative approaches have led to advancements in how blood treatments are administered, making procedures safer and more efficient.
Collaborations
Throughout his career, Leppert has worked alongside talented individuals such as Lori A Truitt and Frank Corbin, III. These collaborations have fostered an environment of innovation and creativity, contributing to the success of their projects.
Conclusion
Lawrence L Leppert's work in the field of extracorporeal blood treatment exemplifies the impact of innovation in healthcare. His patents and collaborations continue to influence medical practices, ultimately benefiting patients in need of advanced treatment options.